Z
ZhuoYan lab
Request Full Data Access to the Medutest database of peptide tests.
Products examined
| Product | Rating | Samples | Avg | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | C | 12 | 6.4 | 4.3 | 8.0 | 4 Aug 2025 |
| Tirzepatide | E | 18 | 6.6 | 2.5 | 9.7 | 2 Jul 2025 |
| ACE-031 | C | 3 | 4.3 | 4.2 | 4.5 | 24 May 2026 |
| Anadrol Oil | C | 3 | 6.2 | 6.1 | 6.2 | 23 May 2026 |
| Anavar (Oxandrolone) | C | 3 | 5.1 | 3.2 | 7.0 | 21 May 2026 |
| ARA-290 | C | 3 | 4.7 | 4.3 | 5.1 | 19 Jan 2026 |
| BMK glycidic acid (P-2-P methyl glycidic acid / sodium salt) CAS 5449-12-7 | X | 1 | 9.6 | 9.6 | 9.6 | 2 Jul 2025 |
| Boldenone Undecylenate (EQ) Raw | C | 2 | 7.2 | 7.0 | 7.3 | 17 May 2026 |
| Cartalax | X | 1 | 8.1 | 8.1 | 8.1 | 21 May 2025 |
| Cerebrolysin | C | 2 | 4.4 | 4.4 | 4.4 | 26 Jan 2026 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | X | 1 | 8.4 | 8.4 | 8.4 | 2 Apr 2025 |
| DHB (1-Test Cyp) Oral | C | 3 | 6.4 | 4.3 | 8.5 | 17 May 2026 |
| Dutasteride | C | 2 | 6.5 | 6.3 | 6.7 | 19 Jan 2026 |
| EAPA (ethyl alpha-phenylacetoacetate / ethyl 3-oxo-2-phenylbutanoate) CAS 5413-05-8 | X | 1 | 7.8 | 7.8 | 7.8 | 24 Apr 2025 |
| Equipoise (Boldenone Undecylenate) | C | 2 | 8.6 | 7.9 | 9.3 | 17 May 2026 |
| GHRP-2 Acetate | C | 2 | 7.9 | 6.9 | 8.8 | 21 May 2026 |
| GLOW GHK-CU 35mg+TB500 10mg+BPC157 5mg | C | 3 | 6.5 | 5.5 | 8.1 | 17 May 2026 |
| GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | C | 3 | 5.9 | 5.7 | 6.4 | 25 May 2026 |
| HMG | C | 2 | 6.0 | 5.3 | 6.8 | 25 May 2026 |
| Hyaluronic acid | X | 1 | 5.4 | 5.4 | 5.4 | 21 May 2025 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | X | 1 | 5.5 | 5.5 | 5.5 | 13 Feb 2025 |
| L-Carnitine 500mg | X | 1 | 5.0 | 5.0 | 5.0 | 24 Apr 2025 |
| Lipo-B 216mg | C | 2 | 8.9 | 8.8 | 9.0 | 20 May 2026 |
| LL37 | C | 2 | 7.2 | 6.9 | 7.5 | 17 May 2026 |
| Oxymetholone (Anadrol) Raw | C | 3 | 7.7 | 7.6 | 7.7 | 17 May 2026 |
| Pancragen | C | 3 | 5.5 | 4.4 | 6.6 | 17 May 2026 |
| Romosozumab | X | 1 | 5.9 | 5.9 | 5.9 | 17 Dec 2024 |
| Selank 10mg + Semax 10mg Blend | X | 1 | 7.7 | 7.7 | 7.7 | 14 Jan 2025 |
| Sildenafil Raw | C | 2 | 7.1 | 5.0 | 9.2 | 26 Jan 2026 |
| Sildenafil (Viagra) | C | 3 | 6.3 | 5.4 | 7.8 | 25 May 2026 |
| Super Shred | C | 3 | 6.2 | 4.0 | 9.2 | 17 May 2026 |
| Tesamorelin 11mg + Ipamorelin 6mg Blend | C | 2 | 5.3 | 4.7 | 5.9 | 25 May 2026 |
| Test Propionate | C | 3 | 7.3 | 5.8 | 8.4 | 24 May 2026 |
| Testagen | C | 3 | 6.4 | 6.1 | 6.9 | 21 May 2026 |
| Testosterone Cypionate Raw | C | 2 | 7.2 | 6.3 | 8.1 | 23 May 2026 |
| Testosterone Phenylpropionate Raw | C | 3 | 5.6 | 4.3 | 6.8 | 26 Jan 2026 |
| Thymosin Alpha-1 | C | 3 | 5.7 | 4.3 | 6.7 | 19 Jan 2026 |
| Vilon | C | 3 | 7.9 | 6.9 | 9.5 | 19 Jan 2026 |
The certificates
| Date | Product | Score | Declared | Measured | Deviation | Purity | Laboratory |
|---|---|---|---|---|---|---|---|
| 25 May 2026 | ARA-290 | 4.9 | 5mg | 5.3mg | +5.8% | 96.64% | Lab E |
| 25 May 2026 | Test Propionate | 8.3 | 250mg/ml | 248.6mg/ml | -0.6% | 97.29% | Lab F |
| 25 May 2026 | Thymosin Alpha-1 | 6.7 | 30mg | 26.5mg | -11.5% | 95.20% | Lab E |
| 24 May 2026 | Boldenone Undecylenate (EQ) Raw | 7.3 | 1g | 1.0g | +3.8% | 98.34% | Lab D |
| 24 May 2026 | Boldenone Undecylenate (EQ) Raw | 9.4 | 100g | 85.9g | -14.1% | 98.44% | Lab A |
| 24 May 2026 | Testagen | 6.5 | 30mg | 26.4mg | -12.1% | 96.41% | Lab F |
| 24 May 2026 | Vilon | 8.0 | 30mg | 27.8mg | -7.2% | 98.75% | Lab C |
| 24 May 2026 | DHB (1-Test Cyp) Oral | 6.2 | 20mg | 22.9mg | +14.4% | 99.60% | Lab C |
| 24 May 2026 | Equipoise (Boldenone Undecylenate) | 7.7 | 250mg/ml | 253.2mg/ml | +1.3% | 97.96% | Lab B |
| 24 May 2026 | Cartalax | 9.4 | 5mg | 5.8mg | +16.1% | 98.38% | Lab F |
| 24 May 2026 | Romosozumab | 6.8 | 30mg | 28.6mg | -4.5% | 99.71% | Lab A |
| 23 May 2026 | Anadrol Oil | 6.9 | 250mg/ml | 254.5mg/ml | +1.8% | 97.20% | Lab A |
| 23 May 2026 | Anavar (Oxandrolone) | 5.1 | 10mg | 9.0mg | -9.9% | 99.66% | Lab A |
| 23 May 2026 | Cerebrolysin | 4.0 | 10mg | 8.5mg | -14.9% | 95.39% | Lab D |
| 23 May 2026 | DHB (1-Test Cyp) Oral | 6.1 | 25mg | 30.7mg | +22.6% | 95.74% | Lab G |
| 23 May 2026 | Dutasteride | 6.3 | 100mg | 92.7mg | -7.3% | 98.67% | Lab G |
| 21 May 2026 | EAPA (ethyl alpha-phenylacetoacetate / ethyl 3-oxo-2-phenylbutanoate) CAS 5413-05-8 | 7.8 | 10g | 10.6g | +6.4% | 97.75% | Lab B |
| 21 May 2026 | Sildenafil Raw | 6.7 | 5g | 4.6g | -8.0% | 99.56% | Lab D |
| 21 May 2026 | Tesamorelin 11mg + Ipamorelin 6mg Blend | 6.2 | 20mg | 24.5mg | +22.4% | 97.48% | Lab D |
| 21 May 2026 | Test Propionate | 8.0 | 200mg/ml | 181.1mg/ml | -9.4% | 98.19% | Lab A |
| 21 May 2026 | Testosterone Cypionate Raw | 8.7 | 1g | 1.2g | +19.2% | 99.02% | Lab F |
| 21 May 2026 | Lipo-B 216mg | 7.3 | 250mg/ml | 241.0mg/ml | -3.6% | 96.28% | Lab A |
| 21 May 2026 | LL37 | 5.9 | 2mg | 1.9mg | -6.7% | 97.77% | Lab E |
| 21 May 2026 | Testagen | 6.7 | 20mg | 24.5mg | +22.7% | 98.71% | Lab D |
| 20 May 2026 | Sildenafil (Viagra) | 6.3 | 25mg | 23.4mg | -6.6% | 98.41% | Lab B |
| 20 May 2026 | Super Shred | 6.2 | 100mg/ml | 117.7mg/ml | +17.7% | 98.06% | Lab E |
| 20 May 2026 | Thymosin Alpha-1 | 6.6 | 10mg | 12.5mg | +24.7% | 99.94% | Lab D |
| 19 May 2026 | Retatrutide | 7.7 | 10mg | 10.6mg | +6.0% | 99.90% | Lab E |
| 19 May 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 7.9 | 15mg | 16.5mg | +10.3% | 97.32% | Lab B |
| 19 May 2026 | Super Shred | 5.5 | 100mg/ml | 108.4mg/ml | +8.4% | 96.28% | Lab C |
| 17 May 2026 | ACE-031 | 4.7 | 2mg | 2.4mg | +21.5% | 97.23% | Lab G |
| 17 May 2026 | Pancragen | 6.7 | 10mg | 8.7mg | -12.9% | 95.29% | Lab G |
| 29 Jan 2026 | Tirzepatide | 8.0 | 10mg | 9.78mg | -2.2% | 99.90% | Lab E |
| 29 Jan 2026 | Tirzepatide | 6.0 | 50mg | 56.2mg | +12.4% | 99.90% | Lab E |
| 29 Jan 2026 | Anavar (Oxandrolone) | 4.3 | 20mg | 22.6mg | +13.1% | 96.95% | Lab F |
| 29 Jan 2026 | GLOW GHK-CU 35mg+TB500 10mg+BPC157 5mg | 9.1 | 50mg | 45.0mg | -10.0% | 96.45% | Lab B |
| 29 Jan 2026 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 5.7 | 30mg | 36.8mg | +22.7% | 96.14% | Lab F |
| 29 Jan 2026 | LL37 | 7.7 | 15mg | 16.4mg | +9.1% | 97.64% | Lab G |
| 26 Jan 2026 | Anadrol Oil | 7.7 | 250mg/ml | 229.5mg/ml | -8.2% | 96.74% | Lab G |
| 26 Jan 2026 | Cerebrolysin | 4.0 | 10mg | 11.8mg | +18.3% | 96.02% | Lab C |
| 26 Jan 2026 | GLOW GHK-CU 35mg+TB500 10mg+BPC157 5mg | 8.8 | 50mg | 60.9mg | +21.7% | 99.41% | Lab G |
| 26 Jan 2026 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 9.0 | 30mg | 28.6mg | -4.8% | 96.44% | Lab A |
| 26 Jan 2026 | Hyaluronic acid | 7.1 | 50mg | 48.2mg | -3.6% | 96.53% | Lab G |
| 26 Jan 2026 | Thymosin Alpha-1 | 5.7 | 2mg | 2.3mg | +13.7% | 97.73% | Lab D |
| 19 Jan 2026 | Tirzepatide | 8.0 | 15mg | 15.6mg | +4.0% | 99.95% | Lab E |
| 19 Jan 2026 | ACE-031 | 4.3 | 10mg | 10.9mg | +9.2% | 99.29% | Lab G |
| 19 Jan 2026 | Dutasteride | 6.9 | 25mg | 23.5mg | -5.8% | 98.59% | Lab B |
| 19 Jan 2026 | Oxymetholone (Anadrol) Raw | 8.6 | 10g | 11.1g | +10.9% | 95.17% | Lab B |
| 15 Jan 2026 | Tirzepatide | 4.8 | 100mg | 117.8mg | +17.8% | 99.70% | Lab G |
| 15 Jan 2026 | Retatrutide | 7.5 | 20mg | 19.7mg | -1.5% | 99.70% | Lab G |
| 15 Jan 2026 | Tirzepatide | 5.4 | 10mg | 11.5mg | +15.0% | 99.80% | Lab G |
| 9 Jan 2026 | Sildenafil Raw | 8.3 | 1g | 1.2g | +15.5% | 96.75% | Lab D |
| 9 Jan 2026 | Super Shred | 5.5 | 100mg/ml | 97.4mg/ml | -2.6% | 96.05% | Lab C |
| 7 Jan 2026 | ARA-290 | 4.2 | 30mg | 36.5mg | +21.5% | 96.08% | Lab G |
| 7 Jan 2026 | GHRP-2 Acetate | 6.6 | 5mg | 5.1mg | +1.2% | 97.04% | Lab C |
| 7 Jan 2026 | GLOW GHK-CU 35mg+TB500 10mg+BPC157 5mg | 7.1 | 5mg | 6.0mg | +19.5% | 95.51% | Lab F |
| 7 Jan 2026 | HMG | 7.3 | 2mg | 2.1mg | +4.5% | 95.12% | Lab D |
| 7 Jan 2026 | Pancragen | 7.2 | 15mg | 17.3mg | +15.5% | 97.29% | Lab A |
| 7 Jan 2026 | Testosterone Phenylpropionate Raw | 4.1 | 5g | 5.1g | +2.2% | 95.45% | Lab G |
| 7 Jan 2026 | Testosterone Phenylpropionate Raw | 6.8 | 100g | 118.1g | +18.1% | 98.88% | Lab D |
| 7 Jan 2026 | Testosterone Phenylpropionate Raw | 6.2 | 500g | 551.7g | +10.3% | 96.36% | Lab D |
| 6 Jan 2026 | ACE-031 | 5.5 | 30mg | 30.5mg | +1.8% | 97.63% | Lab D |
| 6 Jan 2026 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 4.0 | 10mg | 12.5mg | +24.8% | 96.72% | Lab E |
| 6 Jan 2026 | Oxymetholone (Anadrol) Raw | 9.2 | 10g | 12.4g | +24.2% | 97.52% | Lab G |
| 6 Jan 2026 | Testosterone Cypionate Raw | 6.9 | 5g | 4.9g | -1.2% | 97.58% | Lab B |
| 29 Dec 2025 | ARA-290 | 5.1 | 5mg | 4.9mg | -2.2% | 98.56% | Lab D |
| 12 Dec 2025 | BMK glycidic acid (P-2-P methyl glycidic acid / sodium salt) CAS 5449-12-7 | 10.0 | 100g | 118.1g | +18.1% | 99.84% | Lab D |
| 12 Dec 2025 | Vilon | 5.7 | 2mg | 1.7mg | -13.2% | 96.47% | Lab G |
| 5 Dec 2025 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 5.6 | 20mg | 19.2mg | -3.8% | 97.13% | Lab F |
| 5 Dec 2025 | Oxymetholone (Anadrol) Raw | 10.0 | 5g | 5.4g | +8.1% | 96.66% | Lab A |
| 5 Dec 2025 | Tesamorelin 11mg + Ipamorelin 6mg Blend | 5.3 | 10mg | 10.9mg | +8.9% | 97.01% | Lab B |
| 5 Dec 2025 | Test Propionate | 6.4 | 200mg/ml | 207.0mg/ml | +3.5% | 95.98% | Lab F |
| 23 Nov 2025 | Anadrol Oil | 6.9 | 200mg/ml | 176.5mg/ml | -11.8% | 99.64% | Lab F |
| 17 Nov 2025 | DHB (1-Test Cyp) Oral | 7.8 | 20mg | 20.7mg | +3.4% | 96.47% | Lab G |
| 17 Nov 2025 | HMG | 6.7 | 50mg | 58.0mg | +15.9% | 96.60% | Lab E |
| 17 Nov 2025 | Lipo-B 216mg | 7.8 | 250mg/ml | 241.2mg/ml | -3.5% | 98.43% | Lab C |
| 17 Nov 2025 | Sildenafil (Viagra) | 7.4 | 10mg | 12.3mg | +22.5% | 95.55% | Lab G |
| 17 Nov 2025 | Testagen | 5.0 | 5mg | 4.5mg | -10.0% | 95.42% | Lab A |
| 5 Nov 2025 | Equipoise (Boldenone Undecylenate) | 5.8 | 250mg/ml | 244.2mg/ml | -2.3% | 99.96% | Lab C |
| 5 Nov 2025 | Pancragen | 4.7 | 10mg | 9.4mg | -5.5% | 99.21% | Lab C |
| 4 Nov 2025 | GHRP-2 Acetate | 6.8 | 20mg | 23.7mg | +18.3% | 95.23% | Lab D |
| 4 Nov 2025 | Selank 10mg + Semax 10mg Blend | 7.4 | 5mg | 5.5mg | +9.8% | 98.12% | Lab E |
| 9 Oct 2025 | Anavar (Oxandrolone) | 4.1 | 100mg | 103.2mg | +3.2% | 99.29% | Lab F |
| 9 Oct 2025 | L-Carnitine 500mg | 5.1 | 100mg/ml | 88.2mg/ml | -11.8% | 95.21% | Lab D |
| 9 Oct 2025 | Sildenafil (Viagra) | 5.2 | 100mg | 124.7mg | +24.7% | 97.22% | Lab E |
| 3 Oct 2025 | Vilon | 8.1 | 10mg | 12.4mg | +24.3% | 99.40% | Lab G |